Guanfacine Tablet, Extended Release
Product Images NDC 63304-925

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 63304-925). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Guanfacine 4 mg

This is a medication called Guanfacine, which comes in the form of extended-release tablets. The box contains 100 tablets, and the tablets should not be crushed, chewed, or broken before swallowing. There is a warning that it is a prescription-only medication. The rest of the text is not legible or does not provide useful information.*

FDA Label Image

Guanfacine 1 mg

This is a medication label for Guanfacine Extended-Release Tablets. The label advises against crushing, chewing or breaking the tablets before swallowing. It contains information on dosage and quantity (100 tablets). The label is manufactured by Sun Pharmaceutical Industries Inc. However, the dosage strength and usage instructions are not provided.*

FDA Label Image

Guanfacine 2 mg

This is a description of a medication with the NDC (National Drug Code) number 63304-925-01. The medication is Guanfacine, which is an Extended-Release Tablet that contains 2mg of the active ingredient. The tablets should not be crushed, chewed or broken before swallowing. The description also includes a warning that the medication is Rx only.*

FDA Label Image

Guanfacine 3 mg

This is a description for Guanfacine Extended-Release Tablets, USP. The NDC code for the tablets is 63304-926-01. The tablets should not be crushed, chewed, or broken before swallowing. This medication is only available with a prescription.*

FDA Label Image

Figure1 (Image 05)

FDA Label Image

Figure 2 (Image 06)

FDA Label Image

Figure 3 (Image 07)

FDA Label Image

Spl Guanfacine Figure 4

This appears to be a table with two columns and several rows. The first column may represent Treatmen Fare (%) and the second column Tene to Treatment Fasuse (Days). However, without further context it is unclear what this data represents or how it could be used.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.